IN THIS ARTICLE

Citations

1. U.S. Department of Health and Human Services (2010). Genital HSV infections. Sexually Transmitted Diseases Treatment Guidelines 2010 (CDC Publication Vol. 59, No. RR-12), pp. 20–25. Atlanta: U.S. Department of Health and Human Services. Available online: http://www.cdc.gov/std/treatment/2010/STD-Treatment-2010-RR5912.pdf.

2. Corey L, et al. (2004). Once-daily valacyclovir to reduce the risk of transmissioin of genital herpes. New England Journal of Medicine, 350(1): 11–20.

3. Andrews WW, et al. (2006). Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. American Journal of Obstetrics and Gynecology, 194(5): 774–781.

4. Sheffield JS, et al. (2006). Valacyclovir prophylaxis to prevent recurrent herpes at delivery. Obstetrics and Gynecology, 108(1): 141–147.

Other Works Consulted

• American College of Obstetricians and Gynecologists (2007, reaffirmed 2009). Management of herpes in pregnancy. ACOG Practice Bulletin No. 82. Obstetrics and Gynecology, 109(6): 1489–1498.

• Cernik C, et al. (2008). The treatment of herpes simplex infections: An evidence-based review. Archives of Internal Medicine, 168(11): 1137–1144.

• Schiffer JT, Corey L (2010). Herpes simplex virus. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th edition, pp. 1943–1962. Philadelphia: Churchill Livingstone Elsevier.

• Wald A, et al. (2003). Genital herpes. In SA Morse et al., eds., Atlas of Sexually Transmitted Diseases and AIDS, 3rd ed., pp. 241–259. New York: Mosby.